These contradictory results, reduced VEGF serum levels alongside increased microvessel density in DFU of HBOT-treated subjects, can be explained by the fact that local tissue environment plays a pivotal role in the angiogenic process in individuals with diabetes [46]. This evidence concerns the gene VEGFA and diabetes mellitus.